Bristol Myers Squibb
About
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops and delivers medicines for serious diseases, with research operations in Cambridge’s Kendall Square area. Its focus areas are oncology, hematology, immunology, neuroscience and cardiovascular disease, and the company describes itself as combining the agility of a biotech with the reach and resources of an established pharmaceutical company. Its pipeline includes 49 compounds in development across more than 40 disease areas.
The company was formed in 1989 through the merger of Bristol-Myers and Squibb, and it later expanded its hematology and cell therapy work with the 2019 acquisition of Celgene. In cancer, it builds on a long heritage in solid tumors and is exploring immunotherapy in earlier stages of disease. In immunology it targets unmet needs in dermatology, gastroenterology, pulmonology and rheumatology, and its cardiovascular research draws on a 70-year history in the field.
What to Know
- The company provides medical information resources for U.S. healthcare professionals.
- Its neuroscience work includes both disease-modifying and symptomatic therapies.
- Scientific resources on its site are aimed at healthcare professionals, researchers and media.
- It is a member of the Kendall Square Association.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.